This grant is aimed at supporting translational and clinical research, including clinical trials, to enhance our understanding of drug mechanisms in children and pregnant or lactating women. The funding aims to improve drug safety and efficacy in pediatric and obstetric patients, as well as facilitate the development of new drugs or safer use of existing ones for tailored therapies to address specific clinical needs in these populations. Closing date for applications is July 3, 2020.
Opportunity ID: 292195
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-188 |
| Funding Opportunity Title: | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 03, 2017 |
| Last Updated Date: | Apr 13, 2020 |
| Original Closing Date for Applications: | Apr 03, 2020 |
| Current Closing Date for Applications: | Jul 03, 2020 |
| Archive Date: | Aug 02, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments Public and State controlled institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-188.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Close date has been extended | Apr 13, 2020 | |
| Mar 03, 2017 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-188 |
| Funding Opportunity Title: | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 03, 2017 |
| Last Updated Date: | Apr 13, 2020 |
| Original Closing Date for Applications: | Apr 03, 2020 |
| Current Closing Date for Applications: | Jul 03, 2020 |
| Archive Date: | Aug 02, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments Public and State controlled institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-188.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-188 |
| Funding Opportunity Title: | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 03, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 03, 2020 |
| Archive Date: | May 09, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Public housing authorities/Indian housing authorities County governments Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments For profit organizations other than small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-188.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00231156 | Jul 07, 2017 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00236237 | Nov 15, 2017 | Jul 03, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259700 | Jul 07, 2017 | Apr 03, 2020 | View |
Package 1
Mandatory forms
292195 RR_SF424_2_0-2.0.pdf
292195 PHS398_CoverPageSupplement_3_0-3.0.pdf
292195 RR_OtherProjectInfo_1_3-1.3.pdf
292195 PerformanceSite_2_0-2.0.pdf
292195 RR_KeyPersonExpanded_2_0-2.0.pdf
292195 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292195 RR_Budget_1_3-1.3.pdf
292195 RR_SubawardBudget30_1_3-1.3.pdf
292195 PHS398_ModularBudget_1_2-1.2.pdf
292195 PHS_Inclusion_Enrollment_Report-1.0.pdf
292195 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
292195 RR_SF424_2_0-2.0.pdf
292195 PHS398_CoverPageSupplement_4_0-4.0.pdf
292195 RR_OtherProjectInfo_1_4-1.4.pdf
292195 PerformanceSite_2_0-2.0.pdf
292195 RR_KeyPersonExpanded_2_0-2.0.pdf
292195 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
292195 RR_Budget_1_4-1.4.pdf
292195 RR_SubawardBudget30_1_4-1.4.pdf
292195 PHS398_ModularBudget_1_2-1.2.pdf
292195 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
292195 RR_SF424_2_0-2.0.pdf
292195 PHS398_CoverPageSupplement_5_0-5.0.pdf
292195 RR_OtherProjectInfo_1_4-1.4.pdf
292195 PerformanceSite_2_0-2.0.pdf
292195 RR_KeyPersonExpanded_2_0-2.0.pdf
292195 PHS398_ResearchPlan_4_0-4.0.pdf
292195 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
292195 RR_Budget_1_4-1.4.pdf
292195 RR_SubawardBudget30_1_4-1.4.pdf
292195 PHS398_ModularBudget_1_2-1.2.pdf
292195 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
